Operating Expenses Zmiana Data
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Alaunos Therapeutics USD 8.66M 678K 2023-09
ANI Pharmaceuticals USD 124.93M 11.05M 2023-12
Ardelyx USD 48.99M 10.04M 2023-09
Assertio Holdings USD 263.9M 235.33M 2023-09
Aurora Cannabis CAD 141.63M 8.62M 2023-03
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Corcept Therapeutics USD 103.74M 11.31M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Esperion Therapeutics USD 61.5M 1.34M 2023-09
J&J USD 16.57B 435M 2023-12
Knight Therapeutics CAD 79.21M 9.9M 2023-09
Lexicon Pharmaceuticals USD 49.79M 5.24M 2023-09
Merck USD 16.56B 6.35B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Omeros USD 48.15M 7.25M 2023-09
Pacira USD 148.08M 1.87M 2023-12
Pfizer USD 20.8B 4.62B 2023-12
Supernus Pharmaceuticals USD 165.31M 19.57M 2023-12
TG Therapeutics USD 56.46M 5.42M 2023-12



Corcept Therapeutics Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.